The Real Chemistry Podcast

This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date.Panelists Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson Maimah Karmo, CEO & President, Tigerlily Foundation Joan Severson, Chief Innovation Officer, Clinical Ink Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)

Recorded live from SXSW 2023, Founder & Chief Trend Curator of the Non-Obvious Company Rohit Bhargava joins us to discuss why he continues to come back to SXSW, how the event has evolved and his new book co-authored with Henry Coutinho-Mason, The Future Normal, which leans into healthcare trends.

Dr. Keolu Fox, an indigenous futurist and co-founder of the Native BioData Consortium, passionately advocates for diversity in clinical trials. He shares his journey into healthcare and genomics, emphasizing the need to include underserved populations, especially indigenous communities, in research to ensure equitable advancements. He explores how embracing ancestral wisdom can lead to sustainable practices and calls for a more inclusive approach in tech and genomics, highlighting the ethical implications of healthcare innovations.

This week, CEO & Founder of Papa Andrew Parker joins the podcast and discusses how his company is empowering a new kind of healthcare built on human connection. Papa, a platform that connects older adults with Pals who provide companionship and assistance, seeks to address the caregiving shortage and support the US healthcare system’s Triple Aim.

Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.

Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week’s episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries. 

Founder and CEO of The Garage, Pranam Ben, joins us to discuss the future of value-based care and The Garage’s approach of using technology and data to solve for equity and access issues facing the healthcare industry. Read The Garage’s blog post, Tiny Tasty Morsels, to learn about their Quintuple Aim approach to change healthcare for good. 

In this week’s episode, Christopher Boone, PhD, VP & Global Head of Health Economic Outcomes and Research (HEOR) at AbbVie, discusses the changing landscape of HEOR, the importance of leadership, collaboration and innovation in the pharmaceutical industry, and the story behind his Twitter handle, DataHippie.

In this week’s episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.

Huma VP of Primary Care & Clinical Partnerships Harpreet Sood, MD discusses shifts in the digital health market and how Huma differentiates itself through a focus on patient centricity and collaboration across healthcare systems and teams.